Compare CRON & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRON | QDEL |
|---|---|---|
| Founded | N/A | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.8M | 1.0B |
| IPO Year | 2015 | 2022 |
| Metric | CRON | QDEL |
|---|---|---|
| Price | $2.73 | $11.96 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 1.4M | ★ 2.2M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.04 | N/A |
| Revenue | $146,587,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | $26.34 | $3.51 |
| Revenue Next Year | $15.53 | $3.86 |
| P/E Ratio | $68.38 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $1.84 | $9.92 |
| 52 Week High | $3.43 | $35.58 |
| Indicator | CRON | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 47.63 |
| Support Level | $2.44 | $10.86 |
| Resistance Level | $2.83 | $12.85 |
| Average True Range (ATR) | 0.10 | 0.88 |
| MACD | 0.00 | 0.33 |
| Stochastic Oscillator | 45.69 | 71.10 |
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.